Impact Of Rising Diabetes Prevalence On Biguanides Is Supporting Development Across The Biguanides Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Biguanides Market By 2030?

The biguanides market has experienced consistent growth recently. Projections indicate expansion from $5.11 billion in 2025 to $5.28 billion in 2026, achieving a compound annual growth rate (CAGR) of 3.4%. Historically, this expansion is linked to factors such as the increasing prevalence of type 2 diabetes, greater awareness of metabolic disorders, the growing availability of generic biguanides, the adoption of oral antidiabetic medications, and progress in liver-targeted therapies.

The biguanides market is anticipated to experience consistent expansion over the upcoming years. It is projected to reach $5.97 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 3.1%. This projected growth during the forecast period is fueled by factors such as an increasing demand for tailored medical treatments, the broader adoption of telemedicine for diabetes management, a rise in PCOS cases, the creation of innovative combination therapies, and governmental efforts supporting the management of chronic diseases. Key trends expected within this period encompass customized solutions for diabetes management, advancements in combination therapies, new applications extending beyond type 2 diabetes, the expansion of home healthcare and remote patient monitoring services, and the availability of affordable generic biguanides.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15735&type=smp

Which Growth Drivers Are Expected To Support The Biguanides Market Forward?

The increasing incidence of diabetes is projected to fuel the expansion of the biguanides market in the future. This condition is a chronic metabolic ailment marked by high blood sugar, resulting from either inadequate insulin production or compromised insulin action. Factors contributing to the surge in diabetes include evolving lifestyle habits, an aging global population, and enhanced diagnostic awareness. The biguanides market plays a crucial role in diabetes management, functioning by enhancing insulin sensitivity, decreasing glucose production in the liver, and aiding in the reduction of blood sugar levels for those with type 2 diabetes. For example, data released in March 2024 by the Office for Health Improvement & Disparities (OHID), a UK government body, indicated that from March 2022 to March 2023, the proportion of individuals with type 1 diabetes receiving all eight recommended care processes rose by 22%. Concurrently, for type 2 diabetes, this percentage increased by 21%, and the share of patients achieving target HbA1c levels hit 37.9%, representing an unprecedented high. Consequently, the escalating prevalence of diabetes serves as a key impetus for the expansion of the biguanides market.

Which Segment Divisions Form The Structure Of The Biguanides Market?

The biguanides market covered in this report is segmented –

1) By Type: Metformin, Phenformin, Other Types

2) By Dosage Form: Tablets, Oral Solutions

3) By Formulation: Immediate Release, Extended Release

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Metformin: Immediate-Release Metformin, Extended-Release Metformin

2) By Phenformin: Phenformin Hydrochloride

3) By Other Types: Buformin, Metformin Combinations

What Trends Are Driving Changes In The Biguanides Market?

Key companies active in the biguanide market are concentrating on developing sophisticated solutions, including extended-release biguanide formulations. These advancements aim to enhance patient compliance, improve glycemic control, and reduce gastrointestinal side effects. Extended-release biguanide formulations are medications engineered to release their active ingredient progressively over time, thereby maintaining stable blood concentrations, improving tolerability, and supporting superior long-term adherence for individuals managing diabetes. For example, in August 2023, Dr. Reddy’s Laboratories, an India-based biotechnology company, introduced saxagliptin and metformin hydrochloride extended-release tablets. This product is a USFDA-approved generic version of KOMBIGLYZE XR, which combines saxagliptin, a DPP-4 inhibitor, with metformin, a biguanide, providing adults with type 2 diabetes mellitus an effective once-daily treatment option that promotes improved glycemic control when used alongside diet and exercise, while also boosting adherence through its extended-release design.

Which Organizations Are Involved In The Biguanides Market?

Major companies operating in the biguanides market are Pfizer Inc., Sanofi-Aventis LLC, Viatris Inc., Aurobindo Pharma Ltd., Cipla Ltd, Dr. Reddy’s Laboratories, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Apotex Inc, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Mylan Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Panacea Biotech Ltd., Wanbury Ltd, USV Private Limited, Abbott Laboratories

Access The Complete Biguanides Market Report:

https://www.thebusinessresearchcompany.com/report/biguanides-global-market-report

What Is The Largest Regional Market In The Biguanides Market?

Asia-Pacific was the largest region in the biguanides market in 2025. Middle East And Africa is expected to be the fastest-growing region in the forecast period. The regions covered in the biguanides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Biguanides Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=15735&type=smp

Browse Through More Reports Similar to the Global Biguanides Market 2026, By The Business Research Company

Biguanides Market Report 2026

https://www.thebusinessresearchcompany.com/report/biguanides-global-market-report

Artichokes Market Report 2026

https://www.thebusinessresearchcompany.com/report/artichokes-global-market-report

Mushroom Market 2026

https://www.thebusinessresearchcompany.com/report/mushroom-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795